Study: FDA-Approved CBD Formulation Significantly Reduces Seizure Frequency in Young People With Refractory Epilepsy
May 15, 2025
May 15, 2025
WASHINGTON, May 15 [Category: Sociological] -- The National Organization for the Reform of Marijuana Laws posted the following news release:
* * *
Study: FDA-Approved CBD Formulation Significantly Reduces Seizure Frequency in Young People With Refractory Epilepsy
New Orleans, LA: Nearly half of pediatric patients prescribed CBD in the form of Epidiolex achieve a <=25 percent reduction in seizures, according to clinical trial data published in the journal . . .
* * *
Study: FDA-Approved CBD Formulation Significantly Reduces Seizure Frequency in Young People With Refractory Epilepsy
New Orleans, LA: Nearly half of pediatric patients prescribed CBD in the form of Epidiolex achieve a <=25 percent reduction in seizures, according to clinical trial data published in the journal . . .